InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition

MT Newswires Live06-15 22:00

InterCure (INCR) has started a review of US medical cannabis opportunities and completed the first phase of its acquisition of Israel-based cannabis company Botanico, the company said Monday.

The review is focused solely on regulated medical cannabis markets, after the US federal rescheduling of certain state-licensed medical cannabis, InterCure said.

InterCure announced its planned acquisition of Botanico last year, and under the initial closing, agreed to issue about 2.5 million common shares. It will also issue about 2.5 million additional shares following the completion of conditions under the share purchase deal.

InterCure shares were up 4.7% in early trading.

Price: 0.92, Change: +0.04, Percent Change: +4.69

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2643097282?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-15 22:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2643097282","market":"fut","top_or_hot":-1,"title":"InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition","media":"MT Newswires Live","content":"<html><body><p> InterCure (INCR) has started a review of US medical cannabis opportunities and completed the first phase of its acquisition of Israel-based cannabis company Botanico, the company said Monday.</p><p>The review is focused solely on regulated medical cannabis markets, after the US federal rescheduling of certain state-licensed medical cannabis, InterCure said.</p><p>InterCure announced its planned acquisition of Botanico last year, and under the initial closing, agreed to issue about 2.5 million common shares. It will also issue about 2.5 million additional shares following the completion of conditions under the share purchase deal.</p><p>InterCure shares were up 4.7% in early trading.</p><p>Price: 0.92, Change: +0.04, Percent Change: +4.69</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-15 22:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> InterCure (INCR) has started a review of US medical cannabis opportunities and completed the first phase of its acquisition of Israel-based cannabis company Botanico, the company said Monday.</p><p>The review is focused solely on regulated medical cannabis markets, after the US federal rescheduling of certain state-licensed medical cannabis, InterCure said.</p><p>InterCure announced its planned acquisition of Botanico last year, and under the initial closing, agreed to issue about 2.5 million common shares. It will also issue about 2.5 million additional shares following the completion of conditions under the share purchase deal.</p><p>InterCure shares were up 4.7% in early trading.</p><p>Price: 0.92, Change: +0.04, Percent Change: +4.69</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MSOX","symbol_name":"AdvisorShares MSOX 2X Daily ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2643097282","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2643097282","pubTimestamp":1781532039,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"InterCure  has started a review of US medical cannabis opportunities and completed the first phase of its acquisition of Israel-based cannabis company Botanico, the company said Monday.The review is focused solely on regulated medical cannabis markets, after the US federal rescheduling of certain state-licensed medical cannabis, InterCure said.InterCure announced its planned acquisition of Botanico last year, and under the initial closing, agreed to issue about 2.5 million common shares. It will also issue about 2.5 million additional shares following the completion of conditions under the share purchase deal.InterCure shares were up 4.7% in early trading.Price: 0.92, Change: +0.04, Percent Change: +4.69","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MSOX":"AdvisorShares MSOX 2X Daily ETF","TOKE":"Cambria Cannabis ETF","YOLO":"AdvisorShares Pure Cannabis ETF","INCR":"Intercure Ltd","MJ":"Amplify Alternative Harvest ETF","BK4007":"制药","CNBS":"Amplify Seymour Cannabis ETF","MSOS":"AdvisorShares Pure US Cannabis ETF","WEED":"Roundhill Cannabis ETF"},"translate_title":"InterCure开始审查美国医用大麻机会；完成Botanico收购的初步交割","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MJ":1.5,"YOLO":1.5,"WEED":1.5,"MSOX":1.5,"INCR":1,"CNBS":1.5,"MSOS":1.5,"TOKE":1.5},"content_text":"InterCure (INCR) has started a review of US medical cannabis opportunities and completed the first phase of its acquisition of Israel-based cannabis company Botanico, the company said Monday.The review is focused solely on regulated medical cannabis markets, after the US federal rescheduling of certain state-licensed medical cannabis, InterCure said.InterCure announced its planned acquisition of Botanico last year, and under the initial closing, agreed to issue about 2.5 million common shares. It will also issue about 2.5 million additional shares following the completion of conditions under the share purchase deal.InterCure shares were up 4.7% in early trading.Price: 0.92, Change: +0.04, Percent Change: +4.69","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2643097282","isCrawlerRequest":true}